Case report: Intranasal esketamine for severe major depressive disorder with psychotic features

Case report: Intranasal esketamine for severe major depressive disorder with psychotic features

IntroductionAbout one third of patients with major depressive disorder (MDD) have treatment resistant depression (TRD). The difficulty of treating TRD especially in those with suicidal ideation and psychotic features demands treatments that are fast-acting, safe, and effective. Limited access, lack...

Full description

Bibliographic Details
Main Authors: Maximilian Carter, Kassandra Solsrud, Nicholas Mischel
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Psychiatry
Subjects:
esketamine
depression
psychotic
case report
intranasal
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.937996/full

Similar Items

Similar Items